Market revenue in 2023 | USD 13.6 million |
Market revenue in 2030 | USD 23.6 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Anti-bacterial |
Fastest growing segment | Anti-fungal |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-bacterial, Anti-fungal, Corticosteroids, Others (Acaricidals, Cyclosporins) |
Key market players worldwide | Zoetis, Elanco Animal Health Inc, Dechra Pharmaceuticals, Merck & Co Inc, Vetoquinol SA, Virbac SA, CEVA Inc, Penn Veterinary Supply Inc, Vedco |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to companion animal ear infection treatment market will help companies and investors design strategic landscapes.
Anti-bacterial was the largest segment with a revenue share of 44.12% in 2023. Horizon Databook has segmented the Latin America companion animal ear infection treatment market based on anti-bacterial, anti-fungal, corticosteroids, others (acaricidals, cyclosporins) covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of otitis externa in pets, growing overall pet population, and rising demand for veterinary healthcare services are key factors expected to drive the market in Latin America. Despite economic and political problems, the pet industry has remained consistent over the recent past.
According to Global Pets in 2018, pet population—particularly cats—was growing due to urbanization. This market region comprises Brazil, Mexico, and Argentina. The Latin America companion animal ear infection market is highly competitive due to the local presence of several large- and small-scale players.
Most of these companies focus on R&D. partnerships, acquisitions, product approvals, and mergers to gain market share. For example, in September 2020, Virbac announced the acquisition of a range of tilapia vaccines from Ictyogroup.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America companion animal ear infection treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America companion animal ear infection treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account